Physician

Peter A Rapoza

According to 2025 Medicare claims, Peter Rapoza (NPI: 1295727584) practices ophthalmology in the Burlington-South Burlington, VT market, with the plurality of this provider's patient population coming from Chittenden, VT. This provider's primary affiliated billing organization is OPHTHALMIC CONSULTANTS OF VERMONT PC (NPI: 1255416053; TIN: 270062108) and primary practice location at 05403-7613. Rapoza is affiliated with the Mass General Brigham ACO, LLC (ACO ID: A4641), participating under the MSSP model.

Rapoza's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 958 traditional Medicare patients, billed 3,209 HCPCS/CPT codes, and received $518,121 in Medicare payments. The top billing code was 66984 (Removal of cataract with insertion of prosthetic lens). Part D data shows 3,748 prescription claims across 741 beneficiaries totaling $203,416 in drug costs, led by Bromfenac Sodium (Bromfenac Sodium). Open Payments data shows 1 records totaling $133. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Similarly, Part D prescription costs have changed little. In contrast, DME billing represents a smaller volume and changed little.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,317	4,344	$473,743
2016	1,166	3,982	$519,527
2017	1,164	3,428	$537,988
2018	1,220	4,266	$594,210
2019	1,112	3,820	$566,306
2020	743	2,202	$356,032
2021	883	2,687	$435,719
2022	1,031	2,694	$480,511
2023	1,047	3,041	$505,221
2024	958	3,209	$518,121

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	555	2,400	$217,467
2016	684	2,960	$267,428
2017	599	2,438	$239,420
2018	695	2,789	$216,198
2019	674	2,832	$262,075
2020	512	1,919	$206,457
2021	592	2,187	$195,794
2022	677	2,544	$222,524
2023	764	3,007	$258,651
2024	741	3,748	$203,416

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
66984	Removal of cataract with insertion of prosthetic lens	321	746	$293
92014	Established patient complete exam of visual system	685	723	$92
92012	Established patient problem focused exam of visual system	301	319	$74
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	180	251	$71
92136	Measurement of corneal curvature and depth of eye	395	560	$30

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Bromfenac Sodium	Bromfenac Sodium	278	9,193	$45,094
Prednisolone Acetate	Prednisolone Acetate	1,319	37,899	$40,414
Restasis	Cyclosporine	25	1,350	$26,911
Gatifloxacin	Gatifloxacin	607	7,589	$20,565
Loteprednol Etabonate	Loteprednol Etabonate	86	3,908	$11,423

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	1	$133	RxSight Inc
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Peter A. Rapoza?

Tedicare shows public-source Medicare data for Peter A. Rapoza (NPI 1295727584), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Peter A. Rapoza have ACO affiliation data?

Peter A. Rapoza is shown with ACO affiliation data for Mass General Brigham ACO, LLC (MSSP, ACO ID A4641).

What billing organization is linked to Peter A. Rapoza?

Peter A. Rapoza is linked to OPHTHALMIC CONSULTANTS OF VERMONT PC (billing NPI 1255416053) in the available physician profile data.

Does Peter A. Rapoza have Open Payments data?

Peter A. Rapoza has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.